Tarlidocin Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

tarlidocin

infectopharm arzneimittel und consilium gmbh (3291423) - benzylpenicillin-benzathin-tetrahydrat (ph.eur.) ((mit angaben zum dispergier- oder suspendiermittel)); lidocainhydrochlorid-monohydrat - pulver und lösungsmittel zur herstellung einer injektionssuspension - 1,2 millionen i.e. / 25 mg - benzylpenicillin-benzathin-tetrahydrat (ph.eur.) ((mit angaben zum dispergier- oder suspendiermittel)) (13017) 989,2 milligramm; lidocainhydrochlorid-monohydrat (01693) 25 milligramm

Octenident antiseptic 1 mg/ml Lösung zur Anwendung in der Mundhöhle Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

octenident antiseptic 1 mg/ml lösung zur anwendung in der mundhöhle

schülke & mayr gmbh (8010216) - octenidindihydrochlorid - lösung zur anwendung in der mundhöhle - 1 mg/ml - teil 1 - lösung zur anwendung in der mundhöhle; octenidindihydrochlorid (23152) 1 milligramm

Darunavir Vivanta 400 mg Filmtabletten Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunavir vivanta 400 mg filmtabletten

vivanta generics s.r.o. (8174834) - darunavir - filmtablette - 400 mg - teil 1 - filmtablette; darunavir (32142) 400 milligramm

Darunavir Vivanta 600 mg Filmtabletten Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunavir vivanta 600 mg filmtabletten

vivanta generics s.r.o. (8174834) - darunavir - filmtablette - 600 mg - teil 1 - filmtablette; darunavir (32142) 600 milligramm

Darunavir Vivanta 800 mg Filmtabletten Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

darunavir vivanta 800 mg filmtabletten

vivanta generics s.r.o. (8174834) - darunavir - filmtablette - 800 mg - teil 1 - filmtablette; darunavir (32142) 800 milligramm

Celdoxome pegylated liposomal Uniunea Europeană - germană - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doxorubicinhydrochlorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastische mittel - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Azathioprin AqVida 25 mg Filmtabletten Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

azathioprin aqvida 25 mg filmtabletten

aqvida gmbh (8135745) - azathioprin - filmtablette - teil 1 - filmtablette; azathioprin (04347) 25 milligramm

Azathioprin AqVida 50 mg Filmtabletten Germania - germană - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

azathioprin aqvida 50 mg filmtabletten

aqvida gmbh (8135745) - azathioprin - filmtablette - teil 1 - filmtablette; azathioprin (04347) 50 milligramm